IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell ...

Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1 bispecific antibody in development for treating solid ...

Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that its President and CEO, Jayson Rieger, PhD, MBA, will ...

Biodesix is a leading diagnostic solutions company with five Medicare-covered tests available for pulmonology patients. The ...

About Avalyn Pharma. Avalyn is a biopharmaceutical company developing inhaled therapies for the treatment of rare respiratory ...

today announced that it will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference to take place on March 3-5, 2025.

(NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a ...

will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 3:10 p.m. ET in Boston, MA. A live webcast of the presentation will be available on the Nuvation Bio ...

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) has announced its participation in the 45th Annual TD Cowen Health Care ...

announced that it will participate in the 45 th Annual TD Cowen Healthcare Conference including a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time.